COVID 19 in pregnancy: our experience amidst second wave of COVID-19 at a teaching institute


  • Shehla Jamal Department of Obstetrics and Gynaecology, RMRI, Uttar Pradesh, India
  • Kainat Masroor Department of Obstetrics and Gynaecology, RMRI, Uttar Pradesh, India
  • Akansha Tyagi Department of Obstetrics and Gynaecology, RMRI, Uttar Pradesh, India
  • Rajini Agarwal Department of Obstetrics and Gynaecology, RMRI, Uttar Pradesh, India



COVID-19, Pregnancy, Morbidity, Mortality


To analyse the obstetrical outcome during second wave of coronavirus disease 2019 (COVID-19) at Level 2 facility. This is a hospital based analytical study conducted at Raj Shree medical and research institute Bareilly. During second wave a total 87 patients presenting to obstetric emergency department, over a period of one month (April 2021 to May 2021). A total of 26 patients were admitted in the hospital. 20 patients were COVID-19 positive and 6 patients were symptomatic with RT-PCR negative report. Out of 20 patients 19 were antenatal case and 1 case was postnatal. There were 2 mortalities among all positive patients. In all COVID-19 positive patients’ majority of the patients were in 26 to 30 years of age (46%). A High proportion presented in third trimester, at the gestation period between 37 to 40 weeks (54%). Around 23% patients had severe symptoms and there were 4 ICU admissions. 65% patients required supplemental oxygen at a rate of >12 l/min. There were a total 2 mortalities; both were in severe category with rapid deterioration. The significant laboratory derangement observed was coagulation profile deranged in 40% cases. COVID-19 second wave was deleterious for obstetric population in an unprecedented manner. A high morbidity and mortality were seen in this duration. Data and evidence which is continuously evolving needs to be shared for global references and knowledge sharing amongst peers.


COVID-19 India. Available at: Accessed on 20 August 2021.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.

Wu Y, Zhang C, Liu H. Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China. Am J Obstet Gynecol. 2020;223.

Davenport MH, Meyer S, Meah VL, Strynadka MC, Khurana R. Moms are not OK: COVID-19 and maternal mental health. Front Glob Womens Health. 2020;2:21-4.

Yap M, Debenham L, Kew T. PregCOV-19 Consortium. Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol. BMJ Open. 2020;10.

Jamal S, Singh N. COVID-19 in Pregnancy: An Experience at a Dedicated Tertiary Care COVID Facility in Western Uttar Pradesh. Journal of South Asian Federation of Obstetrics and Gynaecology. 2021;13:81-3.

Pandya M, Patel M, Bhesaniya J, Patel S, Patel S, Patel K et al. Pregnancy & Covid 19 infection: Our experience. Indian Journal of Obstetrics and Gynecology Research. 2021;8:15-9.

Bulletin de l'Académie Nationale de Médecine. COVID-19: Interpretation of morbidity and mortality data. 2020;204:e95-6.

Kadiwar S, Smith JJ, Ledot S, Johnson M, Bianchi P, Singh N, et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet. 2021;397:1539-40.






Case Series